The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Deschuytner Brian since 2021.
This trader's CIK number is 1782163.
At the time of last reporting, Deschuytner Brian was the SVP, COO & CFO of Mersana Therapeutics, Inc.. (stock ticker symbol MRSN).
Also see all insider trading activities at Mersana Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | MRSN | 0 | $0 | 14,514 | $8,830 | 37,083 | $0 |
| 2024 | MRSN | 0 | $0 | 23,014 | $52,426 | 76,458 | $0 |
| 2023 | MRSN | 0 | $0 | 5,131 | $29,451 | 16,458 | $0 |
| 2022 | MRSN | 0 | $0 | 0 | $0 | 10,208 | $0 |
| 2021 | MRSN | 0 | $0 | 0 | $0 | 3,959 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-15 | MRSN | Option Ex | 20,833 | .00 | 0 |
| 2025-01-16 | MRSN | Sale | 8,470 | .58 | 4,912 |
| 2025-01-14 | MRSN | Option Ex | 6,250 | .00 | 0 |
| 2025-01-15 | MRSN | Sale | 2,331 | .63 | 1,468 |
| 2025-01-13 | MRSN | Option Ex | 10,000 | .00 | 0 |
| 2025-01-14 | MRSN | Sale | 3,713 | .66 | 2,450 |
| 2024-10-02 | MRSN | Sale | 8,089 | 2.00 | 16,178 |
| 2024-10-03 | MRSN | Sale | 5,598 | 1.96 | 10,972 |
| 2024-10-01 | MRSN | Option Ex | 50,000 | .00 | 0 |
| 2024-01-16 | MRSN | Sale | 9,327 | 2.71 | 25,276 |
| 2024-01-13 | MRSN | Option Ex | 10,000 | .00 | 0 |
| 2024-01-14 | MRSN | Option Ex | 6,250 | .00 | 0 |
| 2024-01-15 | MRSN | Option Ex | 10,208 | .00 | 0 |
| 2023-01-14 | MRSN | Option Ex | 6,250 | .00 | 0 |
| 2023-01-15 | MRSN | Option Ex | 10,208 | .00 | 0 |
| 2023-01-17 | MRSN | Sale | 5,131 | 5.74 | 29,451 |
| 2022-01-14 | MRSN | Option Ex | 10,208 | .00 | 0 |
| 2021-01-15 | MRSN | Option Ex | 3,959 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Deschuytner Brian (SVP, COO & CFO of Mersana Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.